Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Drug Development

Search Results 1 - 10 of 492 records

Tamibarotene eradicates advanced-stage leukemia

(Top News, 11 Aug 2010 )

CytRx announces that an advanced form of acute promyelocytic leukemia, or APL, has been eradicated in former NBA player Ray Johnston following treatment with CytRx's experimental cancer drug tamibarotene. ....


Gamma-Tocotrienol kills prostate cancer stem cells

(Top News, 04 Aug 2010 )

Scientists from Singapore, Australia and Hong Kong have found that gamma-tocotrienol is potent in killing prostate cancer stem cells. This small group of cells is responsible for the initiation of prostate ....


MHRA approved cannabis derived medicine

(Science News, 24 Jun 2010 )

Datamonitor said that UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has granted GW Pharma a license to launch Sativex for the treatment of spasticity in patients with multiple sclerosis ....


Forest and TransTech Enter into License Agreement

(Business News, 09 Jun 2010 )

Forest Laboratories and TransTech Pharma announce that they have entered into a license agreement for the development and commercialisation of small molecule compounds discovered and developed by TransTech. ....


PPD Contract Research Facility Awarded Licenses by Irish Medicines Board

(Business News, 27 May 2010 )

PPD has announced that its contract research facility in Athlone, Ireland, has been awarded manufacturer licenses by the Irish Medicines Board (IMB). The licenses support investigational medicinal products ....


Charles River to Merge with Wuxi

(Business News, 21 May 2010 )

Charles River Laboratories International and WuXi PharmaTech (Cayman) have signed an agreement under which the companies will combine in a cash and stock transaction valued at approximately US$1.6 billion. ....


S*BIO and Onyx Pharmaceuticals Expand Collaboration for JAK2 Inhibitors

(Business News, 19 May 2010 )

S*BIO and Onyx Pharmaceuticals have announced the expansion of their development collaboration and option and license commercialization agreement for the former's JAK2 inhibitors, SB1518 and SB1578, also ....


Amsbio: Easy and Economic Generation of Functional siRNAs

(New Products, 17 May 2010 )

The Turbo Dicer siRNA Generation Kit from Amsbio enables the easy and cost-effective generation of a large number of small interfering Ribonucleic Acid (siRNAs) from full-length target genes. siRNAs are ....


Jeio Tech Introduces High Speed Shakers

(New Products, 14 May 2010 )

Jeio Tech introduces a line of high capacity/high speed shakers that use an engineered direct drive mechanism. A selection of models is available based on platform size and stroke diameter. Programmable ....


Protox Inks Agreement with Kissei for Commercialization of Prostate Disease Treatment

(Business News, 14 May 2010 )

Protox Therapeutics has entered into an exclusive US$75 million license agreement with Kissei Pharmaceutical for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for ....


Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy